NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

China SXT Pharmaceuticals logo
$2.90 -0.10 (-3.18%)
As of 12:41 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About China SXT Pharmaceuticals Stock (NASDAQ:SXTC)

Advanced

Key Stats

Today's Range
$2.80
▼
$2.90
50-Day Range
$2.73
▼
$301.00
52-Week Range
$2.71
▼
$8,375,880.00
Volume
28,395 shs
Average Volume
70,338 shs
Market Capitalization
$299.85 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

China SXT Pharmaceuticals, Inc. develops, manufactures and sells traditional Chinese medicine (TCM) products in China. Its offerings include regular, fine and advanced TCM pieces, which are processed medicinal materials used in preparing traditional remedies or, in some cases, consumed directly.

The company serves customers such as hospitals, pharmacies, pharmaceutical manufacturers and distributors. Its business is based in China, where it operates through subsidiaries focused on processing and supplying TCM products.

China SXT traces its operating history to 2005 and is headquartered in Taizhou, Jiangsu Province. The company was founded by Feng Zhou, who has been identified in company materials as its chairman and chief executive officer.

AI Generated. May Contain Errors.

China SXT Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

SXTC MarketRank™: 
1.059962854865 of 5 stars

China SXT Pharmaceuticals scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    China SXT Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    China SXT Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.

  • Read more about China SXT Pharmaceuticals' stock forecast and price target.
    • Percentage of Shares Shorted

      564.50% of the float of China SXT Pharmaceuticals has been sold short.
    • Short Interest Ratio / Days to Cover

      China SXT Pharmaceuticals has a short interest ratio ("days to cover") of 0.04, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in China SXT Pharmaceuticals has recently decreased by 96.09%, indicating that investor sentiment is improving significantly.
    • Dividend Yield

      China SXT Pharmaceuticals does not currently pay a dividend.

    • Dividend Growth

      China SXT Pharmaceuticals does not have a long track record of dividend growth.

    • News Sentiment

      China SXT Pharmaceuticals has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Healthcare companies.
    • News Coverage This Week

      MarketBeat has tracked 3 news articles for China SXT Pharmaceuticals this week, compared to 2 articles on an average week.
    • Search Interest

      Only 2 people have searched for SXTC on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, China SXT Pharmaceuticals insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      3.95% of the stock of China SXT Pharmaceuticals is held by insiders.

    • Percentage Held by Institutions

      5.02% of the stock of China SXT Pharmaceuticals is held by institutions.

    • Read more about China SXT Pharmaceuticals' insider trading history.
    Receive SXTC Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    SXTC Stock News Headlines

    My $247 scanner for $7
    Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
    See More Headlines

    SXTC Stock Analysis - Frequently Asked Questions

    China SXT Pharmaceuticals' stock was trading at $1,920,000.00 at the beginning of 2026. Since then, SXTC shares have decreased by 100.0% and is now trading at $2.8290.

    China SXT Pharmaceuticals's stock reverse split on Tuesday, February 25th 2025.The 1-8 reverse split was announced on Friday, February 21st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, February 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

    China SXT Pharmaceuticals (SXTC) raised $15 million in an IPO on Friday, January 4th 2019. The company issued 3,750,000 shares at a price of $4.00 per share.

    Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that China SXT Pharmaceuticals investors own include Remark (MARK), NIO (NIO), Sintx Technologies (SINT), T2 Biosystems (TTOO), AIM ImmunoTech (AIM), Aytu BioPharma (AYTU) and Blink Charging (BLNK).

    Company Calendar

    Today
    11/17/2026
    Fiscal Year End
    3/31/2027

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Industry
    Pharmaceuticals
    Sub-Industry
    Pharmaceuticals
    Current Symbol
    NASDAQ:SXTC
    CIK
    1723980
    Fax
    N/A
    Employees
    56
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    0.02
    Current Ratio
    7.94
    Quick Ratio
    7.76

    Sales & Book Value

    Annual Sales
    $1.14 million
    Price / Sales
    0.26
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    103,575
    Free Float
    5,000
    Market Cap
    $293.01 thousand
    Optionable
    Not Optionable
    Beta
    2.02
    The 7 Hottest IPO Stories of 2026 Cover

    MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

    Get This Free Report

    This page (NASDAQ:SXTC) was last updated on 11/17/2026 by MarketBeat.com Staff.
    From Our Partners